Awakening Innovation
With a strategic emphasis on the urgency of global crises such as mental health, antimicrobial resistance, and opioid use recovery, we challenge ourselves to be innovative disruptors and game-changers in the healthcare landscape through our unique Venture Studio model - Awakening Innovation.
We are more than just a pharmaceutical company - we are a collective of scientists, strategists, and visionaries pushing the boundaries of therapeutic discovery and development.
One of our significant achievements is the first-ever authorization from Health Canada's Special Access Program for MDMA use outside a clinical trial. This milestone is a testament to our pioneering spirit and commitment to accelerating change in healthcare.
Through our venture studio model, we aim to create a stream of publicly-trading companies pushing the boundaries of life sciences. By marrying biotech innovation with business acumen, we are accelerating the pathway from lab bench to market, translating cutting-edge science into tangible health outcomes
Investors have the opportunity to be a part of this journey - a journey that redefines pharmaceutical paradigms, drives substantial returns, and brings hope to those grappling with global health crises.
LATEST NEWS
_
Awakening Innovationtm
We Power Outstanding Life Science Companies
_
9390 Langelier
Montréal, Québec
Canada H1P 3H8
_
Terms of Use
Privacy Policy
SHAMAN PHARMA CORP © 2023
Cautionary note: this site and its content my contain sensitive materials reserved to the intended informed adult audience only. Any reference to drugs is within the context of scientific and medical applications and subject to applicable regulations. Any forward-looking statements are unreliable by nature and not statements of historical facts. Nothing herein shall be construed as an offer to buy or sell securities. Use at your own risk.